These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33385575)

  • 21. Design, molecular docking, drug-likeness, and molecular dynamics studies of 1,2,4-trioxane derivatives as novel
    Ghosh S; Chetia D; Gogoi N; Rudrapal M
    BioTechnologia (Pozn); 2021; 102(3):257-275. PubMed ID: 36606151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria.
    Dasgupta T; Chitnumsub P; Kamchonwongpaisan S; Maneeruttanarungroj C; Nichols SE; Lyons TM; Tirado-Rives J; Jorgensen WL; Yuthavong Y; Anderson KS
    ACS Chem Biol; 2009 Jan; 4(1):29-40. PubMed ID: 19146480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based virtual screening approach reveals natural multi-target compounds for the development of antimalarial drugs to combat drug resistance.
    Naik B; Gupta N; Godara P; Srivastava V; Kumar P; Giri R; Prajapati VK; Pandey KC; Prusty D
    J Biomol Struct Dyn; 2024 Sep; 42(14):7384-7408. PubMed ID: 37528665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of PfENR inhibitors: A hybrid structure-based approach in conjunction with molecular dynamics simulations.
    Manhas A; Patel A; Lone MY; Jha PK; Jha PC
    J Cell Biochem; 2018 Nov; 119(10):8490-8500. PubMed ID: 30105881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developments in drug design strategies for bromodomain protein inhibitors to target
    Nguyen HHT; Yeoh LM; Chisholm SA; Duffy MF
    Expert Opin Drug Discov; 2020 Apr; 15(4):415-425. PubMed ID: 31870185
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimalarial properties and molecular docking analysis of compounds from Dioscorea bulbifera L. as new antimalarial agent candidates.
    Chaniad P; Mungthin M; Payaka A; Viriyavejakul P; Punsawad C
    BMC Complement Med Ther; 2021 May; 21(1):144. PubMed ID: 34006257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.
    Kagami LP; das Neves GM; Rodrigues RP; da Silva VB; Eifler-Lima VL; Kawano DF
    Mol Divers; 2017 Aug; 21(3):677-695. PubMed ID: 28523625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical genetics of Plasmodium falciparum.
    Guiguemde WA; Shelat AA; Bouck D; Duffy S; Crowther GJ; Davis PH; Smithson DC; Connelly M; Clark J; Zhu F; Jiménez-Díaz MB; Martinez MS; Wilson EB; Tripathi AK; Gut J; Sharlow ER; Bathurst I; El Mazouni F; Fowble JW; Forquer I; McGinley PL; Castro S; Angulo-Barturen I; Ferrer S; Rosenthal PJ; Derisi JL; Sullivan DJ; Lazo JS; Roos DS; Riscoe MK; Phillips MA; Rathod PK; Van Voorhis WC; Avery VM; Guy RK
    Nature; 2010 May; 465(7296):311-5. PubMed ID: 20485428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Silico Exploration for New Antimalarials: Arylsulfonyloxy Acetimidamides as Prospective Agents.
    Verma S; Debnath U; Agarwal P; Srivastava K; Prabhakar YS
    J Chem Inf Model; 2015 Aug; 55(8):1708-19. PubMed ID: 26237069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computational exploration of compounds in Xylocarpus granatum as a potential inhibitor of Plasmodium berghei using docking, molecular dynamics, and DFT studies.
    Gholam GM; Mahendra FR; Irsal RAP; Dwicesaria MA; Ariefin M; Kristiadi M; Rizki AFM; Azmi WA; Artika IM; Siregar JE
    Biochem Biophys Res Commun; 2024 Nov; 733():150684. PubMed ID: 39293331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein-drug interaction studies for development of drugs against Plasmodium falciparum.
    de Azevedo WF; Caceres RA; Pauli I; Timmers LF; Barcellos GB; Rocha KB; Soares MB
    Curr Drug Targets; 2009 Mar; 10(3):271-8. PubMed ID: 19275563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assay Development and Identification of the First
    Hoarau M; Suwanakitti N; Varatthan T; Thiabma R; Rattanajak R; Charoensetakul N; Redman EK; Khotavivattana T; Vilaivan T; Yuthavong Y; Kamchonwongpaisan S
    Molecules; 2022 May; 27(11):. PubMed ID: 35684452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of new promising Plasmodium falciparum superoxide dismutase allosteric inhibitors through hierarchical pharmacophore-based virtual screening and molecular dynamics.
    Araujo JSC; de Souza BC; Costa Junior DB; Oliveira LM; Santana IB; Duarte AA; Lacerda PS; Dos Santos Junior MC; Leite FHA
    J Mol Model; 2018 Jul; 24(8):220. PubMed ID: 30056475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening and Identification of Inhibitors Against Glutathione Synthetase, A Potential Drug Target of Plasmodium falciparum.
    Kumar YN; Jeyakodi G; Thulasibabu R; Gunasekaran K; Jambulingam P
    Comb Chem High Throughput Screen; 2015; 18(5):492-504. PubMed ID: 26220832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacoinformatics exploration of polyphenol oxidases leading to novel inhibitors by virtual screening and molecular dynamic simulation study.
    Hassan M; Abbas Q; Ashraf Z; Moustafa AA; Seo SY
    Comput Biol Chem; 2017 Jun; 68():131-142. PubMed ID: 28340400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of combined drug treatments on Plasmodium falciparum: In vitro assays with doxycycline, ivermectin and efflux pump inhibitors.
    Nodari R; Corbett Y; Varotto-Boccazzi I; Porretta D; Taramelli D; Epis S; Bandi C
    PLoS One; 2020; 15(4):e0232171. PubMed ID: 32324826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational and experimental elucidation of Plasmodium falciparum phosphoethanolamine methyltransferase inhibitors: Pivotal drug target.
    Singh J; Vijay S; Mansuri R; Rawal R; Kadian K; Sahoo GC; Kumar M; Sharma A
    PLoS One; 2019; 14(8):e0221032. PubMed ID: 31437171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration and validation of diphosphate-based Plasmodium LytB inhibitors using computational approaches.
    Bhuyan R; Seal A
    J Mol Recognit; 2019 Feb; 32(2):e2762. PubMed ID: 30191613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel Plasmodium falciparum PI4KB inhibitors as potential anti-malarial drugs: Homology modeling, molecular docking and molecular dynamics simulations.
    Ibrahim MAA; Abdelrahman AHM; Hassan AMA
    Comput Biol Chem; 2019 Jun; 80():79-89. PubMed ID: 30928871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.